
STLN
Healthcare · Medical Care Facilities · $357.0M market cap
$3.50-0.25 (-6.7%)Nov 13, 4:22 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -191.7% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -0.07 | -0.13 | -85.7% |
| Aug 6, 2026 | After the close | -0.07 | -0.08 | -14.3% |
| May 8, 2026 | Time not confirmed | -0.09 | -0.02 | +77.1% |
| Mar 13, 2026 | Time not confirmed | -0.09 | -0.06 | +33.3% |
| Nov 14, 2025 | Time not confirmed | -0.11 | -0.14 | -23.6% |
| Aug 14, 2025 | Time not confirmed | -0.12 | -0.15 | -25.0% |
| May 15, 2025 | Time not confirmed | — | -0.21 | — |
| Mar 24, 2025 | Time not confirmed | — | -0.14 | — |
| Nov 14, 2024 | Time not confirmed | — | -0.18 | — |
| Aug 14, 2024 | Time not confirmed | — | -0.17 | — |
| May 15, 2024 | Time not confirmed | — | -0.22 | — |
| Mar 28, 2024 | Time not confirmed | — | -0.21 | — |
| Nov 9, 2023 | Time not confirmed | — | -0.19 | — |
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars,…
| Aug 9, 2023 | Time not confirmed | — | -0.19 | — |
| May 11, 2023 | Time not confirmed | — | -0.33 | — |
| Mar 10, 2023 | Time not confirmed | — | -0.15 | — |
| Nov 10, 2022 | Time not confirmed | — | -0.17 | — |
| Aug 10, 2022 | Time not confirmed | — | -0.06 | — |
| Jun 1, 2022 | Time not confirmed | — | 0.25 | — |
| Mar 11, 2022 | Time not confirmed | — | -0.15 | — |